Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 3, 2026

Brilliant Buys for Uncertain Times: 2 Growth Stocks to Own for the Long Term

View original at nasdaq.com
Brilliant Buys for Uncertain Times: 2 Growth Stocks to Own for the Long Term Key Points Amazon has a strong moat in both e-commerce and cloud computing…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If you invested $1,000 in Nvidia when we doubled down in 2009, you'd have $455,872

    60% confidence
  • Apple has one of the best business models on the planet

    60% confidence
  • Investors have started to question when the AI infrastructure spending sprees in tech may peak

    60% confidence
  • Amazon built the greatest e-commerce business on the planet from the ground up

    60% confidence
  • Apple has one of the world's best business models

    60% confidence
  • Amazon is the largest cloud computing company in the world with Amazon Web Services

    60% confidence
  • Amazon pioneered the infrastructure-as-a-service industry and remains the primary computing backbone for much of the digital economy

    60% confidence
  • AI raises many questions about its ultimate impact on businesses and workers

    60% confidence
  • Apple has been able to establish itself as a high-end electronics brand that tends to draw in more affluent customers

    60% confidence
  • Amazon has a strong moat in both e-commerce and cloud computing

    60% confidence
  • Amazon is the largest manufacturer and operator of robots in the world

    60% confidence
  • If you invested $1,000 in Apple when we doubled down in 2008, you'd have $48,676

    60% confidence
  • Amazon offers consumers an unmatched selection of goods that can arrive at their doorsteps sometimes within hours but usually within a day or two for most items

    60% confidence
  • If you invested $1,000 in Netflix when we doubled down in 2004, you'd have $515,294

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Brilliant Buys for Uncertain Times: 2 Growth Stocks to Own for the Long Term — Source | Via News | Finance Via News